| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1085443172 |
| P356 | DOI | 10.1186/S13058-017-0846-1 |
| P932 | PMC publication ID | 5437672 |
| P698 | PubMed publication ID | 28521821 |
| P50 | author | Anant Madabhushi | Q47451241 |
| Nathaniel M Braman | Q59469282 | ||
| P2093 | author name string | Hannah Gilmore | |
| Maryam Etesami | |||
| Pallavi Tiwari | |||
| Prateek Prasanna | |||
| Donna Plecha | |||
| Christina Dubchuk | |||
| P2860 | cites work | Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival | Q37249243 |
| MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays | Q37348196 | ||
| Co-occurrence of Local Anisotropic Gradient Orientations (CoLlAGe): A new radiomics descriptor. | Q37428037 | ||
| Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients | Q37898842 | ||
| Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI. | Q38032028 | ||
| Role of imaging in neoadjuvant therapy for breast cancer. | Q38366386 | ||
| Breast cancer molecular subtype classifier that incorporates MRI features | Q38693206 | ||
| Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy | Q38808843 | ||
| Magnetic resonance imaging texture analysis classification of primary breast cancer | Q40845618 | ||
| Optimal threshold for stromal tumor-infiltrating lymphocytes: its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy | Q41189272 | ||
| Modeling tracer kinetics in dynamic Gd-DTPA MR imaging | Q41352795 | ||
| Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer | Q42488113 | ||
| Measures of divergence of oriented patterns for the detection of architectural distortion in prior mammograms | Q43503669 | ||
| Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study | Q44459282 | ||
| Neoadjuvant treatment of breast cancer. | Q45140936 | ||
| Prognostic relevance of peritumoral vascular invasion in immunohistochemically defined subtypes of node-positive breast cancer. | Q45614106 | ||
| Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy | Q46532153 | ||
| Breast Cancer Heterogeneity: MR Imaging Texture Analysis and Survival Outcomes. | Q51783103 | ||
| Correlation Between MRI and the Level of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer. | Q52842194 | ||
| Tumor-infiltrating lymphocytes in breast cancer: ready for prime time? | Q53584850 | ||
| MRI phenotype of breast cancer: Kinetic assessment for molecular subtypes. | Q53588061 | ||
| Prediction of Clinicopathologic Response of Breast Cancer to Primary Chemotherapy at Contrast-enhanced MR Imaging: Initial Clinical Results | Q62664212 | ||
| Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast | Q68536812 | ||
| Co-occurrence of local anisotropic gradient orientations (CoLIAGe): distinguishing tumor confounders and molecular subtypes on MRI | Q85805594 | ||
| Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer | Q24653339 | ||
| Relevance of tumor-infiltrating lymphocytes in breast cancer | Q26795598 | ||
| How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer | Q26798419 | ||
| Clinical implications of the intrinsic molecular subtypes of breast cancer | Q26800996 | ||
| Why the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkers | Q27023385 | ||
| Minimum redundancy feature selection from microarray gene expression data | Q30988046 | ||
| Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data | Q31042155 | ||
| Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set | Q31142731 | ||
| Clinical significance of angiogenic factors in breast cancer | Q33538444 | ||
| Magnetic resonance imaging features of breast cancer according to intrinsic subtypes: correlations with neoadjuvant chemotherapy effects | Q33690733 | ||
| ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking | Q33896155 | ||
| Breast density and parenchymal texture measures as potential risk factors for Estrogen-Receptor positive breast cancer | Q33954899 | ||
| The relationship between lymphovascular invasion and angiogenesis, hormone receptors, cell proliferation and survival in patients with primary operable invasive ductal breast cancer | Q34245787 | ||
| Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study | Q34409655 | ||
| Radiomic feature clusters and prognostic signatures specific for Lung and Head & Neck cancer | Q34488635 | ||
| A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on DCE-MRI: Preliminary Results in Predicting OncotypeDX Risk Scores | Q34514621 | ||
| Association between Pathological Complete Response and Outcome Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients | Q34779690 | ||
| Update on locally advanced breast cancer | Q35600951 | ||
| Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes - what does it all mean? | Q35782342 | ||
| Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers | Q35782790 | ||
| Breast DCE-MRI Kinetic Heterogeneity Tumor Markers: Preliminary Associations With Neoadjuvant Chemotherapy Response | Q35804283 | ||
| Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study | Q35850871 | ||
| Using computer-extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast cancer pathologic stage | Q35855936 | ||
| Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma | Q35861706 | ||
| Lymphangiogenesis and cancer | Q36137692 | ||
| Classification algorithms for phenotype prediction in genomics and proteomics | Q36389455 | ||
| Applications and limitations of radiomics | Q37052862 | ||
| Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer. | Q37119479 | ||
| P2507 | corrigendum / erratum | Erratum to: Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. | Q42332101 |
| P433 | issue | 1 | |
| P921 | main subject | neoadjuvant chemotherapy | Q108855558 |
| P304 | page(s) | 57 | |
| P577 | publication date | 2017-05-18 | |
| P1433 | published in | Breast Cancer Research | Q2208481 |
| P1476 | title | Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. | |
| P478 | volume | 19 |
| Q92640296 | A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma |
| Q92971601 | A priori prediction of breast tumour response to chemotherapy using quantitative ultrasound imaging and artificial neural networks |
| Q61948598 | A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study |
| Q93173676 | A radiomics model to predict the invasiveness of thymic epithelial tumors based on contrast‑enhanced computed tomography |
| Q57821759 | Application of Radiomics and Decision Support Systems for Breast MR Differential Diagnosis |
| Q90252875 | Artificial Intelligence for Mammography and Digital Breast Tomosynthesis: Current Concepts and Future Perspectives |
| Q64100789 | Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer |
| Q90027636 | Background parenchymal enhancement on breast MRI: A comprehensive review |
| Q90583604 | Breast MRI radiomics for the pretreatment prediction of response to neoadjuvant chemotherapy in node-positive breast cancer patients |
| Q62489932 | CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation |
| Q47788266 | Clinical role of breast MRI now and going forward. |
| Q89794082 | Combination of Peri- and Intratumoral Radiomic Features on Baseline CT Scans Predicts Response to Chemotherapy in Lung Adenocarcinoma |
| Q58804566 | Computed tomography-based radiomics for prediction of neoadjuvant chemotherapy outcomes in locally advanced gastric cancer: A pilot study |
| Q51734273 | DCE-MRI Pharmacokinetic-Based Phenotyping of Invasive Ductal Carcinoma: A Radiomic Study for Prediction of Histological Outcomes. |
| Q47270135 | DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers. |
| Q89823514 | Deep Learning vs. Radiomics for Predicting Axillary Lymph Node Metastasis of Breast Cancer Using Ultrasound Images: Don't Forget the Peritumoral Region |
| Q90450334 | Development and assessment of an individualized nomogram to predict colorectal cancer liver metastases |
| Q64085062 | Early Prediction of Breast Cancer Therapy Response using Multiresolution Fractal Analysis of DCE-MRI Parametric Maps |
| Q42332101 | Erratum to: Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. |
| Q57803278 | Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients |
| Q64124983 | Intratumoral Spatial Heterogeneity at Perfusion MR Imaging Predicts Recurrence-free Survival in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy |
| Q100731098 | Longitudinal radiomics algorithm of posttreatment computed tomography images for early detecting recurrence of hepatocellular carcinoma after resection or ablation |
| Q100750194 | Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers |
| Q58768185 | Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer |
| Q61800828 | Mass Effect Deformation Heterogeneity (MEDH) on Gadolinium-contrast T1-weighted MRI is associated with decreased survival in patients with right cerebral hemisphere Glioblastoma: A feasibility study |
| Q91895322 | Molecular Subtypes Recognition of Breast Cancer in Dynamic Contrast-Enhanced Breast Magnetic Resonance Imaging Phenotypes from Radiomics Data |
| Q64111312 | Multiparametric MRI-based radiomics analysis for prediction of breast cancers insensitive to neoadjuvant chemotherapy |
| Q57456208 | Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set |
| Q90608377 | Perinodular and Intranodular Radiomic Features on Lung CT Images Distinguish Adenocarcinomas from Granulomas |
| Q96816203 | Peritumoral and intratumoral radiomic features predict survival outcomes among patients diagnosed in lung cancer screening |
| Q92647819 | Predicting Breast Cancer in Breast Imaging Reporting and Data System (BI-RADS) Ultrasound Category 4 or 5 Lesions: A Nomogram Combining Radiomics and BI-RADS |
| Q89553811 | Predicting the response to neoadjuvant chemotherapy for breast cancer: wavelet transforming radiomics in MRI |
| Q92735165 | Prediction of Treatment Response to Neoadjuvant Chemotherapy for Breast Cancer via Early Changes in Tumor Heterogeneity Captured by DCE-MRI Registration |
| Q92686150 | Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method |
| Q56761564 | Quantitative analysis of peri-tumor fat in different molecular subtypes of breast cancer |
| Q58111201 | Quantitative variations in texture analysis features dependent on MRI scanning parameters: A phantom model |
| Q57460365 | Quantitative vessel tortuosity: A potential CT imaging biomarker for distinguishing lung granulomas from adenocarcinomas |
| Q99727664 | Radiogenomic signatures reveal multiscale intratumour heterogeneity associated with biological functions and survival in breast cancer |
| Q90679059 | Radiomic Features of Primary Rectal Cancers on Baseline T2 -Weighted MRI Are Associated With Pathologic Complete Response to Neoadjuvant Chemoradiation: A Multisite Study |
| Q92506852 | Radiomic analysis for pretreatment prediction of response to neoadjuvant chemotherapy in locally advanced cervical cancer: A multicentre study |
| Q90580984 | Radiomic analysis of contrast-enhanced ultrasound data |
| Q89534129 | Radiomics as prognostic factor in brain metastases treated with Gamma Knife radiosurgery |
| Q89695893 | Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma |
| Q92057606 | Radiomics-based convolutional neural network for brain tumor segmentation on multiparametric magnetic resonance imaging |
| Q89892322 | Radiomics: from qualitative to quantitative imaging |
| Q58614364 | Role of texture analysis in breast MRI as a cancer biomarker: A review |
| Q91579802 | ShinyLearner: A containerized benchmarking tool for machine-learning classification of tabular data |
| Q99637381 | Supervised Machine Learning in Oncology: A Clinician's Guide |
| Q104060658 | Systematic review of radiomic biomarkers for predicting immune checkpoint inhibitor treatment outcomes |
| Q94564092 | Texture Analysis of Breast DCE-MRI Based on Intratumoral Subregions for Predicting HER2 2+ Status |
| Q62489353 | The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges |
| Q92173404 | The effects of volume of interest delineation on MRI-based radiomics analysis: evaluation with two disease groups |
| Q92865953 | Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics |
| Q64908018 | [Radiomics: Big Data Instead of Biopsies in the Future?] |
| Q42332101 | Erratum to: Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. | main subject | P921 |
Search more.